And rightfully so. Just imagine every CEO whose revenue projection wasn't achieved could be prosecuted by law. We would be in a really bad place where no executive would ever again make forward looking statements. So people who can't make better use of their time than harping on the restated guidance from $15M to $10M-$15M should thoroughly consider ever making any stock investments again. This is similar to blaming the weather forecaster for the weather a year down the road not turning out as projected.
Feel free to believe that FDA approval never comes. But if you are truly (and I mean TRULY) convinced that FlutiCare will be rejected, then is now the right time to sell. Rejection will hurt the share price a lot.
Market Data 
Markets 
AI
